Prescott Group Capital Management, L.L.C.
Position in EBS — Emergent BioSolutions Inc.
CIK 1166152
Tulsa, OK
Position in EBS
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$6,475,820
+$61,821 QoQ
Shares Held
772,771
0.0% QoQ
Ownership
1.51%
of shares outstanding
% of Portfolio
0.61%
of 13F equity value
Holder Rank
#19
of 193 holders
Holding Since
Dec 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EBS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Prescott Group Capital Management, L.L.C. holds $7,877,090 across 2 Drug Manufacturers - Specialty & Generic names. EBS ranks #1 (82.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EBS |
Emergent BioSolutions Inc.
This page
|
772,771 | $6,475,820 | |
| 2 | ZTS |
Zoetis Inc.
|
19,500 | $1,401,270 |
All Filings in EBS
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,475,820 | 772,771 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $6,413,999 | 772,771 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $9,551,449 | 772,771 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,815,840 | 772,771 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,930,278 | 772,771 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,050,481 | 627,671 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,007,600 | 210,000 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $501,000 | 60,000 | Shares | Sole | 2024-11-07 | |
| 2023-12-31 | $2,048,037 | 853,349 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,017,235 | 299,187 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,255,259 | 306,838 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $1,074,710 | 91,000 | Shares | Sole | 2023-02-10 | |
| 2021-12-31 | $1,986,274 | 45,693 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||